Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translation machinery associated 16 homolog pseudogene 1 (TMA16P1) is a genomic locus with high sequence similarity to a functional protein-coding gene involved in cellular translational machinery, but with sequence mutations, insertions, or deletions that prevent translation into a functional protein[1]. Like other pseudogenes, it may theoretically regulate its parental or homologous gene’s expression by acting as a competing endogenous RNA that binds microRNAs, though this specific function has not been validated for TMA16P1[2][3]. Pseudogenes are a class of genomic elements increasingly recognized for potential regulatory and disease relevance[2][3], yet TMA16P1 does not currently have direct evidence for a disease or biomarker role, nor for interaction with drugs or adverse safety implications.
None (not targeted by drugs; pseudogenes are not generally acted upon by mechanism-based therapeutics)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translation machinery associated 16 homolog pseudogene 1 (TMA16P1).